Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02874222 · ClinicalTrials.gov registry record
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms
A clinical trial, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- 13
- Enrollment target
NCT02874222: Completed study, sponsored by United States Naval Medical Center, San Diego.
NCT02874222 is a clinical trial that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02874222 has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Breast cancer is one of the most prevalent cancers with 207,090 new cases of breast cancer and 39,840 deaths in women predicted for 2010 in the United States. Aromatase inhibitors (AIs) are used as first-line adjuvant therapy for postmenopausal women with early stage breast cancer. The effectiveness of current therapy is widely recognized to be compromised by poor compliance because of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS), a syndrome that affects up to 40-50% of women who take these medications. The syndrome that was not recognized during the registration trials for this class of drugs, it can lead to discontinuation in up to 24% of women over 2 years. Knowledge that can be used to prevent discontinuation of these important agents because of severe AIMSS is urgently needed.
Primary Outcome
patients surveyed and given physical exams
Interventions
- OTHER surveys completed by subject
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-05 |
| Est. Completion | 2024-05-01 |
What the finished NCT02874222 record still lists
NCT02874222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which surveys completed by subject is the first listed.
NCT02874222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02874222 about?
NCT02874222 is a clinical study titled "A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms". Breast cancer is one of the most prevalent cancers with 207,090 new cases of breast cancer and 39,840 deaths in women predicted for 2010 in the United States. Aromatase inhibitors (AIs) are used as first-line adjuvant therapy for postmenopausal women with early stage breast cancer. The effectiveness...
What is the current status of trial NCT02874222?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-05. Estimated completion is 2024-05-01.
What interventions are being tested in trial NCT02874222?
The interventions under investigation include: surveys completed by subject (OTHER).
Who is sponsoring clinical trial NCT02874222?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia